secwatch.observer — SEC 8-K summary
======================================

Issuer:     Crinetics Pharmaceuticals, Inc. (CRNX)
CIK:        0001658247
Form:       8-K
Filed at:   2023-12-12T23:59:59+00:00
Accession:  0000950170-23-069747
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Crinetics amends bylaws to adopt universal proxy rules and enhance stockholder proposal disclosures
--------------------------------------------------------------------------------

- Amended bylaws to comply with SEC universal proxy rules, requiring compliance with Rule 14a-19 for soliciting proxies.
- Enhanced procedural and disclosure requirements for stockholder nominations and proposals, including additional background info.
- Requires stockholder solicitors to use a proxy card color other than white.
- Amendments effective December 6, 2023; include technical and clarifying changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1658247/000095017023069747/0000950170-23-069747-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1658247/000095017023069747/crnx-20231206.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-069747

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer